Health & Fitness
Medication Interval Progress Plan Calculator
Map a prescribed interval onto a first-order accumulation timeline, mark observation checkpoints, and distinguish the mathematical approach to steady state from clinical response or dose adjustment.
PK OBSERVATION PLAN
Accumulation curve with scheduled events and observation checkpoints
Dose-event impulses build toward a first-order plateau while separate checkpoint flags show when observations are planned; neither line predicts effect or toxicity.
CHECKPOINT LEDGER
Observation plan across the entered horizon
Each checkpoint reports elapsed half-lives, scheduled events, modeled plateau fraction, and the question to document.
| Checkpoint | Elapsed time | Half-lives | Scheduled events | Plateau fraction | Observation question |
|---|
PLAN SETUP
Use the prescribed regimen as a fixed boundary
- Copy the half-life only from an appropriate medicine reference.
- Enter the prescribed interval without modifying it.
- Choose a horizon long enough to capture the intended observation period.
- Place checkpoints around real follow-up or laboratory plans.
- Log timing and symptoms separately from the PK calculation.
PROGRESS IS NOT CONCENTRATION
A plateau fraction cannot certify benefit, safety, or adherence
The curve describes an idealized fraction of a theoretical steady state. Absorption, active metabolites, organ function, formulation, interactions, and individual response may break the model.
Observation checkpoints are administrative anchors. They do not indicate when a person should increase, decrease, start, stop, or repeat a medication.
ACCUMULATION TIMELINE
Separate the mathematical plateau from clinical progress
A one-compartment first-order model converts half-life into an elimination constant. Repeated equal intervals create a theoretical accumulation factor; the observation plan only places documentation checkpoints.
Detailed calculation process and general formulas
k = ln(2) / t_halfr = exp(-k x tau)R_acc = 1 / (1 - r)t_95 = -ln(0.05) / kN_events = floor(24H / tau) + 1Symbols, meanings, and units
- k
- first-order elimination constant1/hour
- t_half
- reference elimination half-lifehours
- tau
- prescribed intervalhours
- r
- fraction remaining before the next eventdimensionless
- H
- observation horizondays
PLAN AUDIT
Three independent layers keep the timeline honest
The page separates kinetic arithmetic, event timing, and clinical observation.
Kinetic layer
—The half-life determines the mathematical approach to plateau.
Timing layer
—The prescribed interval determines how many events fit the horizon.
Observation layer
—Checkpoints identify what to record, not what dose to take.
Decision takeaway: Use the timeline to prepare accurate records for a prescriber or pharmacist, never to self-adjust a regimen.
OBSERVATION NOTES
Information the equation cannot capture
- Exact administration time and formulation
- Food or fasting conditions
- New medicines or supplements
- Vomiting or absorption concerns
- Kidney or liver changes
- Benefits, adverse effects, and laboratory results
Applied decisions
When a PK observation timeline adds clarity
Early follow-up
A follow-up occurs before four half-lives have elapsed.
What the result clarifies: The page shows that the mathematical plateau is still being approached without judging clinical response.
Logged late event
One administration is later than the prescribed interval.
What the result clarifies: The residual scenario changes, but the calculator does not recommend a catch-up action.
Worked default scenario
Current-input substitution and reconciliation
Method references
Evidence used to frame this specific model
Scope and limitations
Educational first-order pharmacokinetic planning only. Do not use this page to change a prescribed dose, interval, formulation, missed-dose response, or monitoring plan. Contact the prescriber or pharmacist for medicine-specific advice.
Medication Interval Progress Plan Calculator | PK Observation Timeline FAQ
Is 95% plateau the same as full clinical effect?
No. Pharmacodynamic response may lead, lag, or differ from modeled concentration.
Does the plan tell me when to test a drug level?
No. Test timing must follow medicine-specific clinical instructions.
What if the medicine has nonlinear kinetics?
This first-order model may be inappropriate; use medicine-specific professional guidance.
Can the delayed-event result guide a catch-up dose?
No. It is a timing scenario only and must not be used for dosing decisions.